Oral GnRH Antagonist (Linzagolix) Versus Injectable GnRH Antagonist for Ovarian Stimulation in IVF/ICSI | MicrobiomeTrials← Back to trialsNCT07732348
Oral GnRH Antagonist (Linzagolix) Versus Injectable GnRH Antagonist for Ovarian Stimulation in IVF/ICSI
RecruitingEARLY_PHASE1INTERVENTIONAL
Trial Details
Start: 2026-09Est. Completion: 2026-12
Enrollment target: 189 participants Other microbiome trials you might be interested in
Malaria
Background:
Malaria is a disease that affects many people in Africa. It is caused by germs carried by some mosquitoes. …
Ou(SqrRoot)(Copyright)less(SqrRoot)(Copyright)bougou, MaliCompleted Nov 30, 2026
Acute Kidney Injury Due to Sepsis
The purpose of this Ph2b study is to characterize the dose-response relationship and to evaluate the safety and efficacy…
Birmingham, United StatesCompleted Feb 25, 2026
ENROLLING_BY_INVITATION
A multi-center, prospective, single-arm, non-randomized, staged, pivotal clinical study to evaluate the safety and perfo…
Phoenix, United StatesCompleted Jan 2028